Evidence map›Paper›PMID 30718602›Full record

ArticleScientific reports2019

Structural biology workflow for the expression and characterization of functional human sodium glucose transporter type 1 in Pichia pastoris.

Albert Suades, Antonio Alcaraz, Esteban Cruz, Elena Álvarez-Marimon, Julian P Whitelegge, Joan Manyosa, Josep Cladera, Alex Perálvarez-Marín

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. TRPV2: A Key Player in Myelination Disorders of the Central Nervous System.International journal of molecular sciences · 2022
    Article
  5. Methods and protocols · 2021
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Albert SuadesBiophysics Unit, Department of Biochemistry and Molecular Biology, School of Medicine, Universitat Autònoma de Barcelona, 08193, Cerdanyola del Vallés, Catalonia, Spain.
Antonio AlcarazLaboratory of Molecular Biophysics, Department of Physics, Universitat Jaume I, 12071, Castellón, Spain.
Esteban CruzBiophysics Unit, Department of Biochemistry and Molecular Biology, School of Medicine, Universitat Autònoma de Barcelona, 08193, Cerdanyola del Vallés, Catalonia, Spain.
Elena Álvarez-MarimonBiophysics Unit, Department of Biochemistry and Molecular Biology, School of Medicine, Universitat Autònoma de Barcelona, 08193, Cerdanyola del Vallés, Catalonia, Spain.
Julian P WhiteleggeThe Pasarow Mass Spectrometry Laboratory, The NPI-Semel Institute, David Geffen School of Medicine, UCLA, 760 Westwood Plaza, Los Angeles, CA, 90095, USA.
Joan ManyosaBiophysics Unit, Department of Biochemistry and Molecular Biology, School of Medicine, Universitat Autònoma de Barcelona, 08193, Cerdanyola del Vallés, Catalonia, Spain.
Josep CladeraBiophysics Unit, Department of Biochemistry and Molecular Biology, School of Medicine, Universitat Autònoma de Barcelona, 08193, Cerdanyola del Vallés, Catalonia, Spain.
Alex Perálvarez-MarínBiophysics Unit, Department of Biochemistry and Molecular Biology, School of Medicine, Universitat Autònoma de Barcelona, 08193, Cerdanyola del Vallés, Catalonia, Spain. alex.peralvarez@uab.cat.ORCID 0000-0002-3457-0875
Universitat Autònoma de Barcelona · ESUniversitat Jaume I · ES

Funding

Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PETER J TONTONOZ · 2003 to 2026
$40.4M
NIDDK NIH HHS P30 DK063491
6 · The paper itself

Abstract

Heterologous expression of human membrane proteins is a challenge in structural biology towards drug discovery. Here we report a complete expression and purification process of a functional human sodium/D-glucose co-transporter 1 (hSGLT1) in Pichia pastoris as representative example of a useful strategy for any human membrane protein. hSGLT1 gene was cloned in two different plasmids to develop parallel strategies: one which includes green fluorescent protein fusion for screening optimal conditions, and another for large scale protein production for structural biology and biophysics studies. Our strategy yields at least 1 mg of monodisperse purified recombinant hSGLT1 per liter of culture, which can be characterized by circular dichroism and infrared spectroscopy as an alpha-helical fold protein. This purified hSGLT1 transports co-substrates (Na

Indexed as

GlucoseGreen Fluorescent ProteinsHumansMembrane GlycoproteinsMembrane ProteinsMonosaccharide Transport ProteinsPichiaPlasmidsProtein EngineeringRecombinant ProteinsSodiumSodium-Glucose Transporter 1Sodium-Glucose Transport ProteinsWorkflowGlucoseGreen Fluorescent ProteinsMembrane GlycoproteinsMembrane ProteinsMonosaccharide Transport ProteinsRecombinant ProteinsSodiumSodium-Glucose Transporter 1Sodium-Glucose Transport Proteins

Identifiers

PMID30718602
PMCPMC6362292
OpenAlexW2921702965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.